Psychiatry News

Despite widespread support for mental health training in schools, less than half of Americans believe most school staff have received it, according to the results of a recent poll by the American Psychiatric Association.

The ACP recently recommended an evidence-based, public health-focused approach to addressing cannabis use.

PHILADELPHIA — A podcast that offers guidance for living with dementia as well as a space for those with lived experience to share their stories has received favorable reviews, according to a poster.

Almost one in 10 patients treated with prescription opioid painkillers experience opioid dependency or opioid use disorder, a result from a systematic review and meta-analysis showed.

Pregnant women with opioid use disorder treated with buprenorphine combined with naloxone had similar and, in some cases, more favorable neonatal and maternal outcomes vs. treatment with buprenorphine alone, researchers reported in JAMA.

The FDA on Aug. 9 issued a complete response letter to Lycos Therapeutics for its new drug application regarding midomafetamine capsules for the treatment of PTSD, citing insufficient data to approve and requesting an additional phase 3 trial.

Suicide rates among U.S. preteens increased significantly from 2008 to 2022, with the greatest increases being among Hispanic preteens and girls, according to a study published in JAMA Network Open.

As your paycheck grows, so does your discretionary spending and saving. While it is easy to spend, it is not always clear where to invest your next dollar intended for future spending.

Currently, cognitive behavioral therapy for insomnia is the gold standard treatment for sleep disturbances associated with menopause, and research is underway to better target neurons responsible for sleep disturbances.

The FDA approved Zurnai, the first nalmefene hydrochloride auto-injector, for emergency treatment of opioid overdose in adults and youth aged 12 years and older.